How to Help Your Patients Find Procainamide in Stock: A Provider's Guide

When a patient is discharged after an arrhythmia event requiring procainamide, or when an outpatient needs continued access to this medication, providers face a logistical challenge: procainamide is not a drug most retail pharmacies stock. As a prescriber, your guidance is essential in helping patients navigate the access gap between their prescription and a working medication supply.

Why Outpatient Access to Procainamide Is Difficult

Procainamide's access challenges stem from two structural issues in its supply chain:

Oral formulations are permanently discontinued. Pronestyl tablets and Procanbid extended-release tablets are no longer commercially manufactured in the US. Patients who need oral procainamide must obtain it from a compounding pharmacy—an added step that requires specific knowledge from both prescriber and pharmacist.

Injectable formulations are hospital-distribution drugs. The 100 mg/mL and 500 mg/mL injectable concentrations flow primarily through hospital and specialty purchasing channels—not retail pharmacy chains. Even when there is no national shortage, most community pharmacies simply don't carry it.

Step 1: Clarify the Indication and Route of Administration

Before writing a prescription, be specific about whether the patient needs:

Injectable procainamide for acute management (hospital setting or home health infusion service)

Oral procainamide for chronic outpatient maintenance (requires compounding pharmacy)

For patients needing long-term oral procainamide, be aware that the lack of commercially available tablets may create insurance hurdles. Payers may question a compounding prescription if they're unaware that the commercial product has been discontinued.

Step 2: Engage Your Hospital Outpatient Pharmacy First

If your institution has an outpatient pharmacy, this is often the easiest first step. Hospital outpatient pharmacies frequently have access to the same procurement channels as inpatient pharmacies and may be able to dispense procainamide injection for patients with an established indication. Speak with your pharmacy director about outpatient dispensing arrangements.

Step 3: Provide a Compounding Referral for Oral Procainamide

For patients who need oral procainamide, refer them to a PCAB-accredited compounding pharmacy. A compounding prescription for procainamide should include:

Drug name: Procainamide HCl

Dosage form: Capsule or oral suspension

Strength: e.g., 250 mg, 375 mg, or 500 mg capsules

Quantity and directions for use

Medical necessity statement if required for prior authorization

Advise patients that compounded procainamide may take 24–72 hours to be prepared, is not FDA-approved, and may not be covered by their insurance. Out-of-pocket costs vary widely by pharmacy.

39,018+ patients found their medications in stock

39K+

Find Procainamide In Stock Today →

Step 4: Leverage medfinder to Find Pharmacies With Stock

Rather than asking your office staff to call 10 pharmacies, consider directing your patient to medfinder. medfinder contacts pharmacies near the patient and finds which ones can fill their prescription. Results are texted to the patient directly, reducing the coordination burden on your practice.

Step 5: Document the Access Challenge for Insurance Purposes

If your patient is seeking insurance coverage for a compounded oral procainamide formulation, document in the medical record:

That commercial oral procainamide is no longer commercially available in the US

The clinical indication and why procainamide is appropriate for this patient

Why alternative antiarrhythmic agents are not appropriate or have been tried and failed

Skip the calls, skip the stress.

Find Procainamide In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

When to Transition Patients to an Alternative

Consider transitioning the patient to an alternative antiarrhythmic if:

Compounding pharmacy access is not feasible within a clinically appropriate timeframe

Insurance will not cover compounded procainamide and the patient cannot afford out-of-pocket costs

The patient has developed adverse effects (positive ANA, lupus symptoms, CBC abnormalities) requiring discontinuation

Review our full breakdown of procainamide alternatives for a clinical comparison of options by arrhythmia type.